2015 BMT Tandem Meetings: BMT Tandem Saturday Concurrent Luncheon Symposium: Risk Factors and New Methods for Treatment of Myelofibrosis: Transplantation in the Era of JAK Inhibitors

BMT Tandem "Scientific" Meeting

Seaport Ballroom DE (Manchester Grand Hyatt)

Chair:

Parameswaran N. Hari, MD, MS

Disclosures:

P. N. Hari, Sanofi, Celgene, Onyx, Consulting: Honoraria
Millennium, Data Review: Honoraria

Summary:

Supported by an educational grant from Incyte Corporation.

Introduction
Parameswaran N. Hari, MD, MS, CIBMTR/Medical College of Wisconsin

Identifying the Risk Factors and Optimal Timing of HCT Myelofibrosis
Vikas Gupta, MD, Princess Margaret Cancer Center

Evaluating the Benefits of Non-Transplant Treatment Options
Laura C. Michaelis, MD, Medical College of Wisconsin

The Increased Use of Stem Cell Transplantation in Combination with JAK Inhibitor Treatment
Parameswaran N. Hari, MD, MS, CIBMTR/Medical College of Wisconsin

S-S5a BMT Tandem Saturday Concurrent Luncheon Symposium: Risk Factors and New Methods for Treatment of Myelofibrosis: Transplantation in the Era of JAK Inhibitors